Please wait a minute...
Journal of ZheJiang University(Medical Science)  2017, Vol. 46 Issue (5): 462-467    DOI: 10.3785/j.issn.1008-9292.2017.10.02
Accurate imaging diagnosis and evaluation of pancreatic cancer
PAN Yao, CHEN Jieyu, YU Risheng
Department of Radiology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
Download:   PDF(922KB)
Export: BibTeX | EndNote (RIS)      


Pancreatic cancer is a highly malignant tumor and surgical resection is the only curative treatment option. In order to improve the prognosis of patients with pancreatic cancer, it is very important to diagnose and evaluate pancreatic cancer accurately and early. Imaging examinations play an important role in tumor detection, staging and surgical resectability evaluation, which can provide reliable evidences for diagnosis and treatment of pancreatic cancer. At present, the imaging techniques commonly used for diagnosis of pancreatic cancer include conventional ultrasound, endoscopic ultrasonography, PET-CT, multi-detector row CT (MDCT), magnetic resonance imaging (MRI), in which MDCT and MRI are the most widely used. In this article, the application and research progress of imaging in accurate diagnosis and evaluation of pancreatic cancer are reviewed.

Key wordsPancreatic neoplasms/pathology      Tomography,spiral computed      Magnetic resonance imaging      Prognosis      Pancreatic neoplasms/surgery      Review      Pancreatic neoplasms/diagnosis      Neoplasm staging     
Received: 21 April 2017      Published: 25 October 2017
CLC:  R445  
Cite this article:

PAN Yao, CHEN Jieyu, YU Risheng. Accurate imaging diagnosis and evaluation of pancreatic cancer. Journal of ZheJiang University(Medical Science), 2017, 46(5): 462-467.

URL:     OR


胰腺癌是一种高度恶性肿瘤,手术切除是唯一可能治愈的方法。为提高胰腺癌患者的预后,胰腺癌的早期精准诊断与评估非常重要。影像学检查在胰腺癌的发现、肿瘤分期、可切除性评估等方面起重要作用,可以为胰腺癌的诊治提供可靠依据。目前常用于胰腺癌的影像学检查包括常规超声、超声内镜、PET-CT、多层螺旋CT (MDCT)以及磁共振等,不同的影像学检查具有各自的特点,其中MDCT和磁共振应用最广泛。本文对影像学在胰腺癌的精准诊断和评估中的应用研究进展进行综述。

关键词: 胰腺肿瘤/诊断,  胰腺肿瘤/外科学,  磁共振成像,  预后,  综述,  胰腺肿瘤/病理学,  肿瘤分期,  体层摄影术,螺旋计算机 
[[1]]   CONROY T, BACHET J B, AYAV A, et al. Current standards and new innovative approaches for treatment of pancreatic cancer[J]. Eur J Cancer,2016,57:10-22.
[[2]]   HERREROS-VILLANUEVA M, GIRONELLA M, CASTELLS A, et al. Molecular markers in pancreatic cancer diagnosis[J]. Clin Chim Acta,2013,418(1):22-29.
[[3]]   KITAJIMA K, MURAKAMI K, YAMASAKI E, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent pancreatic cancer:comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT[J]. Mol Imaging Biol,2010,12(4):452-459.
[[4]]   FREENY P C, MARKS W M, RYAN J A, et al. Pancreatic ductal adenocarcinoma:diagnosis and staging with dynamic CT[J]. Radiology,1988,166(1 Pt 1):125-133.
[[5]]   SCHIMA W, BA-SSALAMAH A, KOLBLINGER C, et al. Pancreatic adenocarcinoma[J]. Eur Radiol,2007,17(3):638-649.
[[6]]   JUNG K W, KIM M H, LEE T Y, et al. Clinicopathological aspects of 542 cases of pancreatic cancer:a special emphasis on small pancreatic cancer[J]. J Korean Med Sci,2007,22 Suppl:S79-S85.
[[7]]   PROKESCH R W, CHOW L C, BEAULIEU C F, et al. Isoattenuating pancreatic adenocarcinoma at multi-detector row CT:secondary signs[J]. Radiology,2002,224(3):764-768.
[[8]]   YOON S H, LEE J M, CHO J Y, et al. Small (≤ 20 mm) pancreatic adenocarcinomas:analysis of enhancement patterns and secondary signs with multiphasic multidetector CT[J]. Radiology,2011,259(2):442-452.
[[9]]   BALCI N C, SEMELKA R C. Radiologic diagnosis and staging of pancreatic ductal adenocarcinoma[J]. Eur J Radiol,2001,38(2):105-112.
[[10]]   PARK M J, KIM Y K, CHOI S Y, et al. Preoperative detection of small pancreatic carcinoma:value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level[J]. Radiology,2014,273(2):433-443.
[[11]]   BOUJAOUDE J. Role of endoscopic ultrasound in diagnosis and therapy of pancreatic adenocarcinoma[J]. World J Gastroenterol,2007,13(27):3662-3666.
[[12]]   SUGIYAMA Y, FUJINAGA Y, KADOYA M, et al. Characteristic magnetic resonance features of focal autoimmune pancreatitis useful for differentiation from pancreatic cancer[J]. Jpn J Radiol,2012,30(4):296-309.
[[13]]   ICHIKAWA T, SOU H, ARAKI T, et al. Duct-penetrating sign at MRCP:usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas[J]. Radiology,2001,221(1):107-116.
[[14]]   KIM H J, BYUN J H, PARK S H, et al. Focal fatty replacement of the pancreas:usefulness of chemical shift MRI[J]. AJR Am J Roentgenol,2007,188(2):429-432.
[[15]]   ISSEROW J A, SIEGELMAN E S, MAMMONE J. Focal fatty infiltration of the pancreas:MR characterization with chemical shift imaging[J]. AJR Am J Roentgenol,1999,173(5):1263-1265.
[[16]]   TO'O K J, RAMAN S S, YU N C, et al. Pancreatic and peripancreatic diseases mimicking primary pancreatic neoplasia[J]. Radiographics,2005,25(4):949-965.
[[17]]   KIMURA Y, KIKUYAMA M, KODAMA Y. Acute pancreatitis as a possible indicator of pancreatic cancer:the importance of mass detection[J]. Intern Med,2015,54(17):2109-2114.
[[18]]   MENG Z, ZHANG X, ZHENG Q, et al. Acute pancreatitis as an early indicator of pancreatic head carcinoma[J]. Hepatogastroenterology,2014,61(133):1201-1206.
[[19]]   SIEGEL R, MA J, ZOU Z, et al. Cancer statistics, 2014[J]. CA Cancer J Clin,2014,64(1):9-29.
[[20]]   LOYER E M, DAVID C L, DUBROW R A, et al. Vascular involvement in pancreatic adenocarcinoma:reassessment by thin-section CT[J]. Abdom Imaging,1996,21(3):202-206.
[[21]]   LU D S, REBER H A, KRASNY R M, et al. Local staging of pancreatic cancer:criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT[J]. AJR Am J Roentgenol,1997,168(6):1439-1443.
[[22]]   LI H, ZENG M S, ZHOU K R, et al. Pancreatic adenocarcinoma:the different CT criteria for peripancreatic major arterial and venous invasion[J]. J Comput Assist Tomogr,2005,29(2):170-175.
[[23]]   KLAUSS M, MOHR A, VON TENGG-KOBLIGK H, et al. A new invasion score for determining the resectability of pancreatic carcinomas with contrast-enhanced multidetector computed tomography[J]. Pancreatology,2008,8(2):204-210.
[[24]]   MARINELLI T, FILIPPONE A, TAVANO F, et al. A tumour score with multidetector spiral CT for venous infiltration in pancreatic cancer:influence on borderline resectable[J]. Radiol Med,2014,119(5):334-342.
[[25]]   BIPAT S, PHOA S S, VAN DELDEN O M, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma:a meta-analysis[J]. J Comput Assist Tomogr,2005,29(4):438-445.
[[26]]   FERRONE C R, MARCHEGIANI G, HONG T S, et al. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer[J]. Ann Surg,2015,261(1):12-17.
[[27]]   KATZ M H, FLEMING J B, BHOSALE P, et al. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators[J]. Cancer,2012,118(23):5749-5756.
[[28]]   CASSINOTTO C, MOURIES A, LAFOURCADE J P, et al. Locally advanced pancreatic adenocarcinoma:reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy[J]. Radiology,2014,273(1):108-116.
[[29]]   CASSINOTTO C, CORTADE J, BELLEANNEE G, et al. An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment[J]. Eur J Radiol,2013,82(4):589-593.
[[30]]   THOMASSET S C, LOBO D N. Pancreatic cancer[J]. Surgery(Oxford),2010,28(5):198-204.
[[31]]   IMAI H, DOI R, KANAZAWA H, et al. Preoperative assessment of para-aortic lymph node metastasis in patients with pancreatic cancer[J]. Int J Clin Oncol,2010,15(3):294-300.
[[32]]   GOLDER W A. Lymph node diagnosis in oncologic imaging:a dilemma still waiting to be solved[J]. Onkologie,2004,27(2):194-199.
[[33]]   I·NAL A, KOS F T, ALGIN E, et al. Prognostic factors for gemcitabine-refractory patients with advanced pancreatic cancer:a retrospective analysis of a multicentre study (anatolian society of Medical Oncology)[J]. Contemp Oncol (Pozn),2015,19(2):125-129.
[[34]]   BRUEGEL M, HOLZAPFEL K, GAA J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique[J]. Eur Radiol,2008,18(3):477-485.
[[35]]   MOTOSUGI U I T, MORISAKA H, SOU H, et al. Detection of pancreatic carcinoma and liver metastases with gadoxetic acid-enhanced MR imaging_comparison with contrast-enhanced multi-detector row CT[J]. Radiology,2011,260:446-453.
[[36]]   LEE K H, LEE J M, PARK J H, et al. MR imaging in patients with suspected liver metastases:value of liver-specific contrast agent gadoxetic acid[J]. Korean J Radiol,2013,14(6):894-904.
[1] XU Jingjing, TAN Yanbin, ZHANG Minming. Medical imaging in tumor precision medicine: opportunities and challenges[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 455-461.
[2] PAN Jingying, HE Mengye, KE Wei, HU Menglin, WANG Meifang, SHEN Peng. Advances on correlation of PET-CT findings with breast cancer molecular subtypes, treatment response and prognosis[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 473-480.
[3] YANG Rong, YAO Linpeng, ZHANG Siying, CHEN Feng. Rat endothelial progenitor cells labeled with Molday IONTM EverGreen and in vitro MRI study[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 481-486.
[4] ZHANG Siying, CHEN Feng. Research progress of CT/MRI parametric response map in precision evaluation of therapeutic response of cancer patients[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 468-472.
[5] LI Aijing, PAN Yuning, CHEN Bin, XIA Jianbi, GAN Fang, JIN Yinhua, ZHENG Jianjun. Association of parameters in dynamic contrast-enhanced MRI using reference region model with prognostic factors and molecular subtypes of breast cancer[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 505-510.
[6] HU Jing, ZHENG Lu, ZHANG Huanle, ZHANG Sandian, XU Guodong. Expression and prognostic value of memory T lymphocyte in patients with non-small cell lung cancer following radiotherapy[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 523-528.
[7] DONG Fei, LI Qian, JIANG Biao, ZENG Qiang, HUA Jianming, ZHANG Minming. Quantitative analysis of enhanced MRI features for predicting epidermal growth factor receptor gene amplification in glioblastoma multiforme with radiomic method[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 492-497.
[8] WANG Subo, ZHAO Zhenhua, HU Hongjie, YANG Jianfeng, ZHAO Li, YANG Liming, WANG Cheng. Application of dynamic-contrast enhanced magnetic resonance pharmacokinetic models in differential diagnosis of cellular uterine leiomyoma[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 498-504.
[9] WANG Mengyan, ZHU Biao. Research progress on genes mutations related to sulfa drug resistance in Pneumocystis jirovecii[J]. Journal of ZheJiang University(Medical Science), 2017, 46(5): 563-569.
[10] ZHANG Meixia, ZHOU Ying, ZHANG Ruiting, ZHANG Sheng, LOU Min. Maximal infarct volume to benefit from intravenous thrombolysis and its relation with onset to treatment time[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 384-389.
[11] LI Yandie, LU Meiping. Progress on the study of NLRP3 inflammasome in autoinflammatory diseases of children[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 449-453.
[12] LAI Zhenzhen, ZHANG Sheng, ZHONG Genlong, ZHANG Xiaocheng, CHEN Qingmeng, LOU Min. Relationship between dynamic CT angiography-based collateral flow evaluation and outcome of patients with stroke induced by acute basilar artery occlusion[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 371-376.
[13] FENG Xuewen, CHEN Zhicai, ZHONG Genlong, LOU Min. Safety of tirofiban in patients with acute cerebral infarct receiving endovascular therapy[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 397-404.
[14] WANG Qingsong, ZHANG Sheng, ZHANG Meixia, CHEN Zhicai, LOU Min. Collateral score based on CT perfusion can predict the prognosis of patients with anterior circulation ischemic stroke after thrombectomy[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 377-383.
[15] FANG Bing, QIAN Cong, JIANG Dingyao, XU Jing, YU Jun, CHEN Xianyi, XU Liang, CHEN Gao, ZHANG Jianmin. Hypoglossal canal dural arteriovenous fistulas treated with transvenous embolization:report of two cases and literature review[J]. Journal of ZheJiang University(Medical Science), 2017, 46(4): 445-448.